According to research, the newly detected HIV variant from the Netherlands is more transmissible and damaging. Research was led by University of Oxford‘s Big Data Institute.
It showed people living with newly revealed subtype-B of HIV experience double the rate of immune system decline (CD4 count). It higher viral loads and is also vulnerable to developing AIDS two to three times faster. The Joint United Nations Programme on HIV/AIDS (UNAIDS) leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. The study also revealed that the variant has been circulating in the Netherlands for years and remains receptive to HIV treatment. UNAIDS said,”This newly identified variant does not represent a major public health threat but underscores the urgency of speeding up efforts to halt the HIV pandemic.”
The identification of a fast-spreading #HIV variant provides evidence of urgency to halt the pandemic and reach all with testing and treatment.— UNAIDS (@UNAIDS) February 7, 2022
Read press release: https://t.co/6jvZ61208I pic.twitter.com/Yrme77rsF0
“Ten million people living with HIV worldwide are not yet on treatment, fuelling the continued spread of the virus and potential for further variants,” said Eamonn Murphy, UNAIDS Deputy Executive Director, Programme. He added, “We urgently need to deploy cutting-edge medical innovations in ways that reach the communities most in need. Whether it’s HIV treatment or COVID-19 vaccines, inequalities in access are perpetuating pandemics in ways that harm us all.”
HIV remains the deadliest pandemic of our time—an estimated 79 million people have become infected with the virus. HIVstill has no vaccine or cure. The treatment is only antiretroviral therapy. It keeps them alive and well and prevent transmission.
COVID has led to death of 36 millon people related to AIDS and related illness.
In 2020, 1.5 millon people were newly infected with virus. Currently there are 36 millon people living with HIV, out of them 28 million are on life saving antiretroviral therapy.